Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Withdrawn × Ectropion × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9 Polycystic Ovary Syndrome 8 Neoplasms 8 Infertility 5 Liver Neoplasms 4 Pain, Postoperative 3 Carcinoma, Hepatocellular 3 Urinary Bladder Neoplasms 2 Recurrence 2 Pulmonary Embolism 2 Neuroma, Acoustic 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Leiomyoma 2 Inflammation 2 Head and Neck Neoplasms 2 Febrile Neutropenia 2 Colorectal Neoplasms 2 Bites and Stings 2 Anovulation 2 Vomiting 1 Venous Thrombosis 1 Venous Thromboembolism 1 Unipolar Major Depression 1 Surgical Wound Infection 1 Stomatitis 1 Stomach Neoplasms 1 Sleep Initiation and Maintenance Disorders 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02761083 2016-06-10

OPHTHALNOQ

Aesculap AG

Phase 4 Withdrawn

Blepharoptosis, Ectropion, Entropion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡